Treatment benefit evaluation from the patients perspective: The patient benefit index (PBI) as an example of goal-oriented preference and outcomes measurement;Evaluation des therapeutischen nutzens aus patientensicht: Der patient benefit index (PBI) als beispiel für zielorientierte präferenz- und outcome-messung

Gesundheitsokonomie und Qualitatsmanagement

Volumn 15, Issue 5, 2010, Pages 236-240

  Blome, C ^a   Augustin, M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

outcomes measurement; patient preferences; patient reported outcomes; quality of life; skin diseases

Indexed keywords

ARTICLE; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HUMAN; PATIENT BENEFIT INDEX; STRUCTURED QUESTIONNAIRE;

EID: 78049400987     PISSN: 14322625     EISSN: 14394049     Source Type: Journal    
DOI: 10.1055/s-0029-1245662     Document Type: Article

References (20)

1. Gemeinsamer Bundesausschuss. Verfahrensordnung vom 20.09.2005. Bundesanzeiger 2005; 242: 16998
2. GKV-WSG. Gesetz zur Stärkung des Wettbewerbs in der gesetzlichen Krankenversicherung vom 26.03.2007. Bundesanzeiger 2007 66 3613
3. Bastian H, Bender R, Ernst A et al. Methoden. Version 2.0 vom 19.12.2006 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen Köln 2007
4. Zschocke I, Hammelmann U, Augustin M. Therapeutischer Nutzen in der dermatologischen Behandlung. Hautarzt 2005 56 839-846
5. Zentner A, Velasco-Garrido M, Busse R. Methoden zur vergleichenden Bewertung pharmazeutischer Produkte. HTA-Bericht DIMDI 2005
6. EuroQol Group. EuroQol a new facility for the measurement of health-related quality of life. Health Policy 1990 16 199-208
7. Hurst N P., Kind P, Ruta D et al. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 1997 36 551-559
8. Ware J, Snow K. SF-36 Health Survey Manual an Interpretation Guide. Boston MA 1993
9. Bullinger M, Kirchberger I. SF-36 Fragebogen zum Gesundheitszustand (SF-26 Questionnaire concerning Health status). Hogrefe Göttingen, Bern, Toronto, Seattle 1993
10. Finlay A, Khan G. Dermatology Life Quality Index (DLQI) a simple practical measure for routine clinical use. Clin Exp Dermatol 1994 19 210-216
11. Chren M, Lasek R, Quinn L et al. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 1996 107 707-713
12. Kiresuk T, Sherman R. Goal Attainment Scaling: A General Method for Evaluating Comprehensive Community Mental Health Programs. Community Mental Health Journal 1968 4 443-453
13. Kiresuk T Smith A Cardillo J Hrsg. Trainig in Goal Attainment Scaling. Hillsdale, New Jersey Lawrence Erlbaum Associates 1994 105-118
14. Gerdes N. Rehabilitationseffekte bei zielorientierter Ergebnismessung: Ergebnisse der IRES-ZOE-Studie 1996 / 97. Deutsche Rentenversicherung 1998 3 4 217-238
15. Augustin M, Radtke M A., Zschocke I et al. Patient benefit index (PBI) a novel approach in patient-defined outcomes measurement for skin diseases. Arch Dermatol Res 2009 301 (8) 561-571
16. Blome C, Maares J, Diepgen T et al. Measurement of patient-defined benefits in the treatment of chronic hand eczema a novel approach. Contact Dermatitis 2009 61 (1) 39-45
17. Augustin M, Schäfer I, Rabini S et al. Assessing the Value of Supportive Skin Care: Development and Validation of an Instrument for Evaluating Patient-Relevant Benefit. Dermatology 2009 218 255-259
18. Blome C, Augustin M, Siepmann D et al. Measuring Patient-relevant Benefits in Pruritus treatment: Development and Validation of a Specific Outcomes Tool. Br J Dermatol 2009 161 (5) 1143-1148
19. Augustin M, Gajur A, Reich C et al. Benefit Evaluation in Vitiligo treatment: Development and Validation of a Patient-Defined Outcomes Questionnaire. Dermatology 2008 217 101-106
20. Blome C, Augustin M, Behechtnejad J et al. Dimensions of patient needs in dermatology: subscales of the Patient Benefit Index. Arch Dermatol Res 2010 in press